Effects of Volume Loading and Pressor Agents in Idiopathic Orthostatic Tachycardia
- 15 July 1997
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (2) , 575-580
- https://doi.org/10.1161/01.cir.96.2.575
Abstract
Idiopathic orthostatic tachycardia (IOT) is characterized by an increase in heart rate (HR) with standing of > or = 30 bpm that is associated with elevated catecholamine levels and orthostatic symptoms. A dynamic orthostatic hypovolemia and alpha1-adrenoreceptor hypersensitivity have been demonstrated in IOT patients. There is evidence of an autonomic neuropathy affecting the lower-extremity blood vessels. We studied the effects of placebo, the alpha1-adrenoreceptor agonist midodrine (5 to 10 mg), the alpha2-adrenoreceptor agonist clonidine (0.1 mg), and I.V. saline (1 L) in 13 patients with IOT. Supine and upright blood pressure (BP) and HR were measured before and at 1 and 2 hours after intervention. Midodrine decreased both supine and upright HR (all HR values are given as bpm) at 2 hours (from 78+/-2 supine to 108+/-5 upright before treatment and from 69+/-2 supine to 95+/-5 upright after treatment, P<.005 for supine and P<.01 for upright). Saline decreased both supine and upright HR (from 80+/-3 supine to 112+/-5 upright before infusion and from 77+/-3 supine to 91+/-3 upright 1 hour after infusion, P<.005 for supine and P<.001 for upright). Clonidine decreased supine HR (from 78+/-2 to 74+/-2, P<.03) but did not affect the HR increase with standing. Clonidine very significantly decreased supine systolic BP (from 109+/-3 at baseline to 99+/-2 mm Hg at 2 hours, P<.001), and midodrine decreased supine systolic BP mildly. IOT responds best acutely to saline infusion to correct the underlying hypovolemia. Chronically, this can be accomplished with increased salt and water intake in conjunction with fludrocortisone. The response of patients to the alpha1-agonist midodrine supports the hypothesis of partial dysautonomia and indicates that the use of alpha1-agonists to pharmacologically replace lower-extremity postganglionic sympathetics is an appropriate overall goal of therapy. These findings are consistent with our hypothesis that the tachycardia and elevated catecholamine levels associated with IOT are principally due to hypovolemia and loss of adequate lower-extremity vascular tone.Keywords
This publication has 12 references indexed in Scilit:
- Evaluation of Autonomic FailurePublished by Taylor & Francis ,2019
- Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophyNeurology, 1996
- The Anemia of Primary Autonomic Failure and its Reversal with Recombinant ErythropoietinAnnals of Internal Medicine, 1994
- Long-acting α1-adrenoceptive sympathomimetic agent suppresses sympathetic outflow to muscles in humansJournal of the Autonomic Nervous System, 1991
- Pathogenesis of hyperadrenergic orthostatic hypotension. Evidence of disordered venous innervation exclusively in the lower limbs.Journal of Clinical Investigation, 1990
- Idiopathic HypovolemiaAnnals of Internal Medicine, 1986
- Vasoconstrictor effects of midodrine, ST 1059, noradrenaline, etilefrine and norfenefrine on isolated dog femoral arteries and veinsGeneral Pharmacology: The Vascular System, 1983
- Postural tachycardia syndromeThe American Journal of Medicine, 1982
- Clonidine-Suppression TestNew England Journal of Medicine, 1981
- Mineralocorticoid-Induced Hypertension in Patients with Orthostatic HypotensionNew England Journal of Medicine, 1979